Serum estradiol levels are not associated with urinary incontinence in midlife women transitioning through menopause

Menopause

Volumn 18, Issue 12, 2011, Pages 1283-1290

  Waetjen, L Elaine ^a   Johnson, Wesley O ^b   Xing, Guibo ^a   Feng, Wen Ying ^c   Greendale, Gail A ^d   Gold, Ellen B ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b 5226 Donald Bren Hall   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Epidemiology; Estradiol; Menopause transition; Prospective cohort study; Reproductive hormones; Urinary incontinence

Indexed keywords

ESTRADIOL; FOLLITROPIN; PRASTERONE SULFATE; TESTOSTERONE;

ADULT; ANXIETY; BLOOD SAMPLING; BODY MASS; CONFERENCE PAPER; DIABETES MELLITUS; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; IMMUNOASSAY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MENOPAUSE; MENSTRUAL CYCLE; MULTICENTER STUDY; QUESTIONNAIRE; STRESS INCONTINENCE; TESTOSTERONE BLOOD LEVEL; URGE INCONTINENCE; WEIGHT GAIN;

ADULT; DISEASE PROGRESSION; ESTRADIOL; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; ODDS RATIO; PERIMENOPAUSE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; UNITED STATES; URINARY INCONTINENCE, STRESS; URINARY INCONTINENCE, URGE;

EID: 83055173017     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e31821f5d25     Document Type: Conference Paper

References (31)

1. Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L. Metaanalysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1998;92:722-727. (Pubitemid 28440818)
2. Jarmy-Di Bella ZI, Girao MJ, Sartori MF, et al. Power Doppler of the urethra in continent or incontinent, pre-and postmenopausal women. Int Urogynecol J Pelvic Floor Dysfunct 2000;11:148-154; discussion 154-155.
3. Fantl JA, Cardozo L, McClish DK. Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1994;83:12-18. (Pubitemid 24027373)
4. Elia G, Bergman A. Estrogen effects on the urethra: beneficial effects in women with genuine stress incontinence. Obstet Gynecol Surv 1993; 48:509-517. (Pubitemid 23184704)
5. Sacco F, Rigon G, Carbone A, Sacchini D. Transvaginal estrogen therapy in urinary stress incontinence [in Italian]. Minerva Ginecol 1990; 42:539-544.
6. Grady D, Brown JS, Vittinghoff E, Applegate W, Varner E, Snyder T. Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol 2001;97:116-120. (Pubitemid 32057168)
7. Hendrix SL, Cochrane BB, Nygaard IE, et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA 2005;293:935-948. (Pubitemid 40271125)
8. Waetjen LE, Feng WY, Ye J, et al. Factors associated with worsening and improving urinary incontinence across the menopausal transition. Obstet Gynecol 2008;111:667-677. (Pubitemid 351654072)
9. Waetjen LE, Ye J, Feng WY, et al. Association between menopausal transition stages and developing urinary incontinence. Obstet Gynecol 2009;114:989-998.
10. Teleman PM, Persson J, Mattiasson A, Samsioe G. The relation between urinary incontinence and steroid hormone levels in perimenopausal women. A report from the Women's Health in the Lund Area (WHILA) study. Acta Obstet Gynecol Scand 2009;88:927-932.
11. Gopal M, Sammel MD, Arya LA, Freeman EW, Lin H, Gracia C. Association of change in estradiol to lower urinary tract symptoms during the menopausal transition. Obstet Gynecol 2008;112:1045-1052.
12. Sowers M, Crawford S, Sternfeld B, et al. SWAN: a multicenter, multiethnic, community-based cohort study of women and the menopausal transition. In: Lobo RA, Kelsey JL, Marcus R, eds. Menopause: Biology and Pathobiology. San Diego, CA: Academic Press, 2000:175-188.
13. England BG, Parsons GH, Possley RM, McConnell DS, Midgley AR. Ultrasensitive semiautomated chemiluminescent immunoassay for estradiol. Clin Chem 2002;48:1584-1586. (Pubitemid 34925797)
14. Barsky AJ, Goodson JD, Lane RS, Cleary PD. The amplification of somatic symptoms. Psychosom Med 1988;50:510-519.
15. Radloff L. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
16. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med 1991;32:705-714.
17. Moos RH, Fenn CB, Billings AG, Moos BS. Assessing life stressors and social resources: applications to alcoholic patients. J Subst Abuse 1988;1:135-152.
18. Gold EB, Colvin A, Avis N, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: Study of Women's Health Across the Nation. Am J Public Health 2006;96:1226-1235. (Pubitemid 43967848)
19. Blakeman PJ, Hilton P, Bulmer JN. Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status. BJU Int 2000;86:32-38. (Pubitemid 30420760)
20. Gebhart JB, Rickard DJ, Barrett TJ, et al. Expression of estrogen receptor isoforms < and A messenger RNA in vaginal tissue of premenopausal and postmenopausal women. Am J Obstet Gynecol 2001;185:1325-1330; discussion 1330-1321.
21. Greendale GA, Chu J, Ferrell R, Randolph JF Jr, Johnston JM, Sowers MR. The association of bone mineral density with estrogen receptor gene polymorphisms. Am J Med 2006;119:S79-S86. (Pubitemid 44292106)
22. Sowers MR, Wilson AL, Kardia SR, Chu J, McConnell DS. CYP1A1 and CYP1B1 polymorphisms and their association with estradiol and estrogen metabolites in women who are premenopausal and perimenopausal. Am J Med 2006;119:S44-S51. (Pubitemid 44292102)
23. Sowers MR, Wilson AL, Karvonen-Gutierrez CA, Kardia SR. Sex steroid hormone pathway genes and health-related measures in women of 4 races/ethnicities: the Study of Women's Health Across the Nation (SWAN). Am J Med 2006;119:S103-S110. (Pubitemid 44292107)
24. Reichler IM, Hung E, Jochle W, et al. FSH and LH plasma levels in bitches with differences in risk for urinary incontinence. Theriogenology 2005;63:2164-2180. (Pubitemid 40483198)
25. Copas P, Bukovsky A, Asbury B, Elder RF, Caudle MR. Estrogen, progesterone, and androgen receptor expression in levator ani muscle and fascia. J Womens Health Gend Based Med 2001;10:785-795. (Pubitemid 33062088)
26. Jung BH, Bai SW, Chung BC. Urinary profile of endogenous steroids in postmenopausal women with stress urinary incontinence. J Reprod Med 2001;46:969-974.
27. Edwall L, Carlstrom K, Jonasson AF. Endocrine status and markers of collagen synthesis and degradation in serum and urogenital tissue from women with and without stress urinary incontinence. Neurourol Urodyn 2007;26:410-415. (Pubitemid 46717591)
28. Brown JS, Grady D, Ouslander JG, Herzog AR, Varner RE, Posner SF. Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group. Obstet Gynecol 1999;94:66-70. (Pubitemid 29284428)
29. Jackson RA, Vittinghoff E, Kanaya AM, et al. Urinary incontinence in elderly women: findings from the Health, Aging, and Body Composition Study. Obstet Gynecol 2004;104:301-307. (Pubitemid 40458876)
30. Bradley CS, Rovner ES, Morgan MA, et al. A new questionnaire for urinary incontinence diagnosis in women: development and testing. Am J Obstet Gynecol 2005;192:66-73. (Pubitemid 40164222)
31. Brown JS, Bradley CS, Subak LL, et al. The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence. Ann Intern Med 2006;144:715-723. (Pubitemid 46780631)